Importance Hematopoietic stem cell transplant (HSCT) is an advisable option for refractory
or relapsed peripheral T-cell lymphoma (R/R-PTCL), but whether allogeneic HSCT or …

The peripheral T-cell lymphomas (PTCL) are relatively rare, heterogeneous, and
therapeutically challenging. While significant therapeutic gains and improved understanding …

Peripheral T-cell lymphoma (PTCL) is a heterogeneous group of hematological cancers
arising from the malignant transformation of mature T cells. In a cohort of 28 PTCL cases, we …

Nodal peripheral T‐cell lymphoma (PTCL) with a T follicular helper phenotype (PTCL‐TFH)
is a new type of PTCL. We aimed to define its clinical characteristics and prognosis …

The use of post-transplantation cyclophosphamide (PTCy) for graft-versus host-disease
(GVHD) prophylaxis has revolutionized allogeneic blood or marrow transplantation …

Nodal T-follicular helper cell lymphoma (T-FHCL) derived from T-follicular helper (Tfh) cell
falls into a heterogeneous category of peripheral T-cell lymphoma (PTCL). Due to the limited …

Purpose: Patients with peripheral T-cell lymphomas (PTCL) in the relapsed or refractory (r/r)
setting have only a limited number of therapies available, and the prognosis is extremely …

Purpose Plasma circulating tumor DNA (ctDNA) could reflect the genetic alterations present
in tumor tissues. However, there is little information about the clinical relevance of cell-free …

While the peripheral T-cell lymphomas (PTCL) remain a therapeutic challenge, and
increasingly account for a disproportionate number of lymphoma-related deaths, improved …

Background: Peripheral T-cell lymphoma (PTCL) is an extensive class of biologically and
clinically heterogeneous diseases with dismal outcomes. The histone deacetylase inhibitor …